Stay updated on Safety and Immune Response to Dolutegravir in Pediatric HIV Clinical Trial

Sign up to get notified when there's something new on the Safety and Immune Response to Dolutegravir in Pediatric HIV Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety and Immune Response to Dolutegravir in Pediatric HIV Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The study has officially closed to accrual and follow-up was completed on October 18, 2023, with new details on genotypic and phenotypic measures of resistance to integrase, protease, and reverse transcriptase genes, while previous ongoing study references and interim data summaries have been removed.
    Difference
    10%
    Check dated 2024-12-15T00:24:50.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study and includes a reference to the Contacts and Locations section.
    Difference
    1%
    Check dated 2024-12-07T21:51:31.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    The website has added new features while removing detailed options for participant groups, interventions, and various data fields for downloads.
    Difference
    2%
    Check dated 2024-11-23T06:25:44.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    Several key resources related to HIV and clinical trials have been removed, including links to MedlinePlus and multiple PubMed articles.
    Difference
    0.3%
    Check dated 2024-11-16T02:09:01.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    The website has been updated to version v2.12.2, adding numerous links to clinical trial documents and PubMed articles, while removing the previous version v2.12.1.
    Difference
    3%
    Check dated 2024-11-08T19:20:10.000Z thumbnail image
  8. Check
    55 days ago
    Change Detected
    Summary
    The website has been updated from version 2.12.0 to 2.12.1.
    Difference
    0.0%
    Check dated 2024-11-01T11:44:45.000Z thumbnail image

Stay in the know with updates to Safety and Immune Response to Dolutegravir in Pediatric HIV Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety and Immune Response to Dolutegravir in Pediatric HIV Clinical Trial page.